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Abstract
Clostridium perfringens-induced necrotic enteritis is generally controlled by antibiotics. How-
ever, because of increasing antibiotic resistance, other antibacterial agents are required,
preferably ones that do not affect the beneficial intestinal microbiota of the host. This study
evaluated the in vitro selective growth-inhibitory effect of 8-hydroxyquinoline (8HQ) on C.
perfringens vs. bifidobacteria in a medium containing chicken ileal digesta. Prior to the
experiments, the minimum inhibitory concentrations of 8HQ and penicillin G were deter-
mined by broth microdilution assay. The minimum inhibitory concentration values of 8HQ for
C. perfringens were 16–32 times lower than the values for bifidobacteria. Treatment of auto-
claved and non-autoclaved chicken ileal digesta with 8HQ showed a selective anticlostridial
effect. After incubation of C. perfringens with autoclaved ileal digesta for 3 h, all 8HQ con-
centrations tested (32–2048 μg/mL) significantly reduced C. perfringens bacterial count. In
contrast, the same treatment had no or only a slight effect on bifidobacteria counts. Unlike
8HQ, penicillin G did not exhibit any selectivity. Similar results were obtained after incuba-
tion for 24 h. In non-autoclaved ileal digesta, all 8HQ concentrations tested significantly
reduced C. perfringens bacterial counts after incubation for 30 min and 3 h, while no effect
was observed on bifidobacteria. These results suggest that 8HQ may serve as a prospective
veterinary compound for use against necrotic enteritis in poultry.
Introduction
The control of Clostridium perfringens, a causative agent of avian necrotic enteritis (NE), has
been of both health and economic significance to poultry production worldwide. It commonly
manifests as a subclinical infection [1,2]. In addition, NetB toxin production, dietary factors,
Eimeria co-infection, and stress are believed to be crucial factors influencing the development
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of NE [2]. An imbalance in the microbial community, where commensal bacteria, such as Lac-
tobacillus spp. and Bifidobacterium spp., do not compete with pathogens for adhesion sites or
nutrients, can promote intestinal colonization by pathogenic bacteria. Since the colonization
and rapid proliferation of C. perfringens in the small intestine is one of the principal factors
that induce NE in birds, competitive microbiota, such as bifidobacteria, can lower the risk of
clostridial adhesion and thus decrease the risk of NE occurrence [3].
Until now, NE has usually been controlled using various conventional antibiotics such as
bacitracin and penicillin [1,4,5]. However, their use is well known to result in the development
of antibiotic resistance. This has led to the regulated use of antibiotics in both veterinary and
human medicine. In addition, antibiotics are known for their ability to affect not only the tar-
get microorganism but also the beneficial microbiota in both humans and animals, including
poultry [6,7].
The above-mentioned concerns have prompted efforts to develop other types of antimicro-
bial agents. Plant-derived compounds have been proposed as prospective alternatives to con-
ventional antibiotics in veterinary medicine [8]. In addition, the limitations of the antibiotics
commonly used for treating clostridial infections have led to a search for new agents with bet-
ter anticlostridial selectivity over the normal gut microbiota [9]. One of the possible candidates
is 8-hydroxyquinoline (8HQ), a quinolone alkaloid of plant origin that is currently used as a
topical bacteriostatic and fungistatic agent in human medicine. The antibacterial effect of 8HQ
and its derivatives has been observed in vitro toward Clostridium spp., Escherichia coli, and
Staphylococcus aureus [10]. Apart from its wide range of antimicrobial properties, including
antibacterial, antiviral, and antiparasitic effects [10], 8HQ has been shown to inhibit the in
vitro growth of Clostridium spp., including C. perfringens; however, it exerts a significantly
lower effect on bifidobacteria [11,12]. Its selective effect has been confirmed against C. difficile
and Bifidobacterium longum subsp. longum in a co-culture analyzed by flow cytometry [13]. It
has been found that 8HQ helps in isolating bifidobacteria from human and animal feces, espe-
cially when there is a risk of clostridial contamination [14].
Control of NE in poultry by using anticlostridial agents can be evaluated in vivo by using
experimentally infected animal models. However, avian NE is a complex multi-factorial dis-
ease [15,16,17], in which other factors (such as co-infection with Eimeria, immunosuppressive
viruses, or dietary modifications) contribute to its induction [17,18]. Unfortunately, those
interventions may significantly affect the experimental design. Thus, to study the impact of
8HQ on C. perfringens, the effect of the anticlostridial agents can be tested in vitro, in a rela-
tively controlled medium of chicken intestinal contents [19,20]. Furthermore, according to the
principles of the 3 Rs (replacement, reduction, and refinement), in vitro techniques should be
used, when possible, to reduce animal suffering and improve well-being [21].
In this context, evaluation of new selective anticlostridial agents is highly desirable for their
possible use in poultry veterinary practice. Therefore, the objective of this study was to evaluate
the in vitro selective effect of 8HQ on C. perfringens in a medium of the chicken intestinal sys-
tem, and to compare its effect with that of penicillin.
Materials and Methods
Chemicals
With the exception of Wilkins–Chalgren anaerobic broth, soy peptone, tryptose sulfite cyclo-
serine (TSC) agar, and egg yolk emulsion (Oxoid CZ, Brno, Czech Republic), all other chemi-
cals (8HQ, agarose, bacitracin, buffer concentrate, cysteine, glycerol, mupirocin, penicillin G,
RedTaq Ready Mix, and Tris-acetate-EDTA [TAE]) were purchased from Sigma-Aldrich
(Prague, Czech Republic). The stock solution of 8HQ was prepared in dimethyl sulfoxide
8-Hydroxyquinoline and Clostridium perfringens/Bifidobacteria
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(DMSO, Lach-Ner, Neratovice, Czech Republic). Penicillin G was dissolved at appropriate
concentrations deionized water.
Bacterial strains and media
Three isolates of C. perfringens and 3 Bifidobacterium spp. strains were used in this study. C.
perfringens CIP 105178 was obtained from the Collection of Institut Pasteur (Paris, France). C.
perfringens CCM 4435 and B. animalis CCM 4988 were purchased from the Czech Collection
of Microorganisms (Brno, Czech Republic). C. perfringens 56, a clinical isolate from a case of
chicken NE, was obtained from a culture collection at Ghent University (Ghent, Belgium).
This strain is resistant to rifampicin, well characterized, and shown to be suitable for inducing
experimental infections [22]. B. longum TP1, a clinical isolate from human feces, was obtained
from a collection of microorganisms at the Department of Microbiology, Nutrition and Dietet-
ics at the Czech University of Life Sciences (Prague, Czech Republic). B. gallinarum DSM
20670 was obtained from the Leibniz Institute DSMZ (Braunschweig, Germany). Clostridia
and bifidobacteria were both incubated and stored in Wilkins–Chalgren anaerobic broth,
which was supplemented with soy peptone (5 mg/mL) and cysteine (0.5 mg/mL). For storage
at −20˚C, glycerol at a final concentration of 15% (v/v) was used as a cryoprotectant.
Minimum inhibitory concentration (MIC) determination
The broth microdilution method [23], which was modified according to the recommendations
proposed for effective assessment of the antimicrobial potential of natural products [24], was
used for measuring 8HQ MIC in 96-well microtiter plates. Briefly, a two-fold dilution range
of 8HQ in the broth was used, starting with an initial concentration of 2048 μg/mL. Each sam-
ple, excluding the negative control (no bacterial strain and no antibacterial agent in the well),
was inoculated with a standardized bacterial suspension of 106 CFU/mL. For inoculum stan-
dardization, the turbidity of the bacterial suspension was adjusted to 0.5 McFarland standard
(1.5 × 108 CFU/mL) using a Densi-La-Meter II (Lachema, Neratovice, Czech Republic) spec-
trophotometric device. Penicillin G (0.031–2μg/mL) was assayed in each plate as a positive
control. The plates were prepared in an anaerobic chamber (Bugbox, BioTrace, Bridgend, UK)
and subsequently incubated for 48 h at 37˚C in an anaerobic jar (Anaerobic Plus System,
Oxoid). The bacterial growth was measured in terms of the turbidity using a Multiskan Ascent
microplate reader (Thermo Fisher Scientific, USA) at 405 nm. MIC was defined as the concen-
tration that resulted in a greater than 80% inhibition of the microbial growth relative to a
growth control. The tests were performed in triplicate in 3 independent experiments. The
mode values were used for MIC determination. The solvents used as the negative control did
not inhibit the growth of any strain tested.
Assaying the effect of chicken ileal digesta (ID) on the growth-inhibitory
activity of 8HQ
To simulate the natural intestinal conditions in chicken, the effect of 8HQ was evaluated in the
presence of chicken ID, under both autoclaved (to avoid interference from background micro-
biota) and non-autoclaved conditions. Initially, the activity of 8HQ against each of the 6 bacte-
rial strains was examined in the presence of autoclaved ileal contents. Subsequently, its effect
on the clinical isolate C. perfringens 56 was determined in the presence of the non-autoclaved
ID. Under both the autoclaved and non-autoclaved ID conditions, the inhibitory activity of
8HQ was evaluated at 4 concentrations (32, 128, 512, and 2048 μg/mL). Penicillin G was
included at concentrations of 0.25, 1, 4, and 16 μg/mL as an antibiotic control in each experi-
ment. Penicillin G was selected in accordance with a previous experiment that showed its
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stronger antibacterial activity compared to bacitracin. The concentration range for both 8HQ
and penicillin G was selected according to the results of the previously described susceptibility
test, whereas the initial concentrations correspond to the MIC values determined in the previ-
ous experiment. A positive control (an inoculated medium with ID at a 1:1 ratio, no treatment)
and a negative control (a non-inoculated medium with ID at a 1:1 ratio, no treatment) were
included. For the experiment using non-autoclaved contents, a growth control (an inoculated
medium with no ID added) was also included within each incubation set.
Growth-inhibitory activity of 8HQ in the presence of autoclaved chicken
intestinal contents
To perform this set of experiments, the methodology of Si et al. [25] and Vasudevan et al. [26]
was used, with some modifications. For each tested bacterial strain (3 clostridia and 3 bifido-
bacteria strains), 3 independent incubations were performed as follows: A composite sample
of ileal contents, obtained from 30 clinically healthy, 35-day-old Ross 308 broiler chickens
(Xavergen, Kostelec nad Cernymi lesy, Czech Republic) receiving a commercial wheat- and
corn-based feed mixture free of any antimicrobial agents, was collected and aseptically placed
into gas-tight glass flasks (3 g for each experimental sample) containing Wilkins–Chalgren
anaerobic broth (3 mL), buffered with sodium phosphate buffer (pH 7.2). The flasks were
flushed with CO2, closed with rubber stoppers, and autoclaved at 121˚C for 15 min. After
autoclaving, appropriate quantities of 8HQ or penicillin G were added. All samples, excluding
the negative control, were subsequently inoculated with one of the tested bacterial strains. An
inoculum was prepared for each tested strain by suspending the 24-h-grown culture in the
broth to achieve a turbidity equivalent to that of the McFarland standard (108 CFU/mL). Each
sample was inoculated with 0.3 mL of the diluted culture (final density, 107 CFU/mL). The
samples were incubated anaerobically at 42˚C, in triplicate. At 0, 3, and 24 h of incubation, the
bacterial counts of C. perfringens and bifidobacteria were determined by plating 100 μL of the
appropriate dilution (decimally diluted in sterile peptone water) on selective agar plates. For C.
perfringens and Bifidobacterium spp. quantification, TSC agar with egg yolk and modified Wil-
kins–Chalgren agar with mupirocin were used, respectively [27]. Suspected bacterial colonies
were confirmed by microscopy (Eclipse E200, Nikon, Nikon Instruments Europe BV, The
Netherlands). Differences in bacterial counts for each treated group, compared to the positive
control were determined by SAS, using t-test [28].
Growth-inhibitory effect of 8HQ in the presence of non-autoclaved
chicken intestinal contents
For this set of experiments, the modified method of Namkung et al. [29] was used. To assess
the effect of 8HQ on the clinical isolate C. perfringens 56 in a medium containing the back-
ground microbiota present in fresh intestinal contents, the methodology was adjusted as fol-
lows: Thirty composite samples of ileal contents were diluted at a 1:1 ratio, as described above.
After adding the appropriate quantities of 8HQ or penicillin G, all samples, excluding the
negative control, were inoculated with rifampicin-resistant C. perfringens 56 at the same final
density as in the previous experiment. In this assay, the rifampicin-resistant C. perfringens bac-
terial count was determined, in addition to the total C. perfringens and bifidobacteria counts
(representing the background microbiota). The concentrations of 8HQ and penicillin G were
similar to those in the previous experiment; however, the incubation periods were changed to
30 min and 3 h. Rifampicin-resistant C. perfringens growth was evaluated on Wilkins–Chalg-
ren agar containing 20 mg/mL of rifampicin. The total C. perfringens count was determined
on Wilkins–Chalgren agar with no rifampicin added. The Bifidobacterium spp. count was
8-Hydroxyquinoline and Clostridium perfringens/Bifidobacteria
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determined after incubation for 24 h on modified Wilkins–Chalgren agar with mupirocin
[27]. The results were analyzed statistically as described above. The bacterial colonies were
confirmed by microscopy. In the case of C. perfringens, suspected colonies were further con-
firmed by PCR on an iQ5 thermocycler (BioRad, USA), using RedTaq Ready Mix primers.
The PCR conditions were adjusted according to the methodology of Wise and Siragusa [30].
The template used for the PCR procedure was prepared as described by Kanakaraj et al. [31]
with a few modifications: Each suspected colony was suspended in 50 μL of sterile distilled
water, boiled for 10 min, and centrifuged at 10,000 g for 5 min. The supernatant was used as a
template for the PCR reaction. The amplified products were visualized by electrophoresis in
2% agarose in TAE buffer at 100 V for 45 min.
Results
In this study, the in vitro selective growth-inhibitory effect of 8HQ on clostridia was deter-
mined by broth microdilution and 2 other assays based on incubation in the presence of auto-
claved and non-autoclaved ileal contents.
The broth microdilution test results (Table 1) revealed a clear selective growth-inhibitory
effect of 8HQ on the 3 tested strains of C. perfringens (MIC = 32 μg/mL), compared to the 3
bifidobacteria strains (MICs = 512 and 1,024 μg/mL). Penicillin G exerted a stronger, but non-
selective, clostridial/bifidobacterial growth-inhibitory effect, where the growth of all tested
strains was inhibited most frequently at a concentration of 0.25 μg/mL, with the exception of
B. longum TP1 (MIC = 0.125 μg/mL).
The effect of 8HQ and penicillin G on C. perfringens (3 strains), B. longum, B. animalis, and
B. gallinarum was evaluated further in a medium containing autoclaved chicken ileal contents
(Tables 2 and 3). After an incubation period of 3 h (Table 2), all tested concentrations of 8HQ
(32–2048 μg/mL) significantly reduced the count of C. perfringens (p 0.01) compared to the
untreated control (8HQ = 0 μg/mL). In contrast, the same treatment had no significant effect
on the B. longum count. In the case of B. gallinarum and B. animalis, only the highest concen-
tration of 8HQ (2048 μg/mL) showed significant bacterial reduction (p 0.01). Conversely,
penicillin G did not act selectively, and led to a significant reduction in the growth of all tested
bacteria (p 0.01). After incubation for 24 h, the antibacterial activity was similar to the
activity observed after incubation for 3 h, with the exception of B. animalis, where 8HQ sig-
nificantly reduced the bacterial growth (p 0.01) at the 2 highest concentrations after 24 h
(Table 3). In addition, treatment of C. perfringens CIP 105178 with the highest concentration
of 8HQ reduced the bacterial counts below the detection limit (2 log10 CFU/g).
Table 1. In Vitro Antibacterial Effect of 8-Hydroxyquinoline (8HQ), Penicillin G toward C. perfringens
and Selected Bifidobacteria.
Bacterium MICa, b (μg/mL)
8HQ Penicillin G
C. perfringens 56 32 0.25
C. perfringens CCM 4435 32 0.25
C. perfringens CIP 105178 32 0.25
B. longum TP1 1024 0.125
B. animalis CCM 4988 512 0.25
B. gallinarum DSM 20670 512 0.25
aMinimum inhibitory concentration, i.e. the median value of tested concentrations, resulting in a greater than
80% inhibition of growth relative to a growth control.
bResults of 3 independent experiments, each performed in triplicate.
doi:10.1371/journal.pone.0167638.t001
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All tested concentrations of 8HQ and penicillin G significantly reduced (p 0.01) the
counts of both total and rifampicin-resistant C. perfringens when tested in a medium contain-
ing non-autoclaved ID (Tables 4 and 5). With the exception of the lowest concentration
Table 2. Effects of 8-Hydroxyquinoline (8HQ) and Penicillin G on Autoclaved Ileal Contents of Broiler Chickens Artificially Inoculated with C. per-
fringens and Selected Bifidobacteria (CFU/g)a after Incubation for 3 h at 42˚C.
Treatment Concentration
(μg/mL)
C. perfringens
56
C. perfringens
CCM 4435
C. perfringens CIP
105178
B. longum
TP1
B. animalis CCM
4988
B. gallinarum DSM
20670
8HQ 32 6.27 ± 0.25* 6.35 ± 0.35* 6.62 ± 0.59* 7.46 ± 0.33 7.07 ± 0.50 6.95 ± 0.16
128 5.60 ± 0.36* 5.75 ± 0.26* 6.48 ± 0.50* 7.65 ± 0.11 6.84 ± 0.78 6.95 ± 0.07
512 4.75 ± 0.36* 4.8 ± 0.34* 4.89 ± 0.59* 7.28 ± 0.44 6.85 ± 0.83 6.75 ± 0.28
2048 3.63 ± 0.06* 3.71 ± 0.34* 3.70 ± 0.72* 6.97 ± 0.86 6.60 ± 0.21* 6.17 ± 0.21*
Penicillin G 0.25 5.85 ± 0.59* 5.90 ± 0.17* 5.98 ± 0.29* 7.30 ± 0.29 6.95 ± 0.33 6.69 ± 0.86*
1 5.58 ± 0.80* 5.52 ± 0.54* 4.73 ± 0.38* 6.94 ± 0.34* 6.67 ± 0.35* 6.42 ± 0.75*
4 5.75 ± 0.74* 5.83 ± 0.41* 4.57 ± 0.51* 6.65 ± 0.37* 6.34 ± 0.35* 6.73 ± 0.95*
16 4.74 ± 0.81* 5.56 ± 0.54* 4.05 ± 0.10* 6.56 ± 0.49* 6.40 ± 0.15* 6.17 ± 0.32*
Control
groups
Positive
controlb
0 7.37 ± 0.54 7.39 ± 0.34 7.39 ± 0.53 7.67 ± 0.32 7.08 ± 0.34 7.16 ± 0.38
Negative
controlc
0 < 2* < 2* < 2* < 2* < 2* < 2*
aColony-forming units, means ± SD of 3 independent experiments.
bInoculated samples with no 8HQ or penicillin G added to the incubation mixture.
cNon-inoculated samples with no 8HQ or penicillin G added to the incubation mixture.
*Values in the same column differ significantly from the positive control (p 0.01).
doi:10.1371/journal.pone.0167638.t002
Table 3. Effects of 8-Hydroxyquinoline (8HQ) and Penicillin G on Autoclaved Ileal Contents of Broiler Chickens Artificially Inoculated with C. per-
fringens and Selected Bifidobacteria (CFU/g)a after Incubation for 24 h at 42˚C.
Treatment Concentration
(μg/mL)
C. perfringens
56
C. perfringens
CCM 4435
C. perfringens CIP
105178
B. longum
TP1
B. animalis CCM
4988
B. gallinarum DSM
20670
8HQ 32 7.46 ± 0.48* 7.09 ± 0.35* 5.24 ± 0.28* 9.26 ± 0.30 9.81 ± 0.09 9.02 ± 0.08
128 6.48 ± 0.60* 5.70 ± 0.43* 4.30 ± 0.61* 9.27 ± 0.44 9.83 ± 0.12 9.09 ± 0.12
512 4.34 ± 0.37* 5.59 ± 0.36* 3.39 ± 0.53* 9.16 ± 0.43 8.35 ± 0.11* 8.79 ± 0.36
2048 3.43 ± 0.51* 3.78 ± 0.3* < 2* 8.50 ± 0.34 7.31 ± 0.36* 6.02 ± 0.74*
Penicillin G 0.25 3.43 ± 0.56* 3.53 ± 0.92* 2.78 ± 0.77* 4.11 ± 0.19* 5.71 ± 0.27* 5.62 ± 0.43*
1 3.16 ± 0.15* 2.93 ± 0.83* < 2* 4.19 ± 0.37* 5.22 ± 0.42* 5.51 ± 0.19*
4 2.72 ± 0.12* 2.43 ± 0.38* < 2* 3.74 ± 0.28* 5.05 ± 0.35* 5.73 ± 0.35*
16 2.43 ± 0.51* < 2* < 2* 3.79 ± 0.74* 4.16 ± 1.04* 5.86 ± 0.11*
Control
groups
Positive
controlb
0 8.90 ± 0.35 9.07 ± 0.32 9.09 ± 0.62 9.04 ±0.07 9.75 ± 0.26 9.03 ± 0.06
Negative
controlc
0 < 2* < 2* < 2* < 2* < 2* < 2*
aColony-forming units, means ± SD of 3 independent experiments.
bInoculated samples with no 8-HQ or penicillin G added to the incubation mixture.
cNon-inoculated samples with no 8-HQ or penicillin G added to the incubation mixture.
*Values in the same column differ significantly from the positive control (p 0.01).
doi:10.1371/journal.pone.0167638.t003
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(0.25 μg/mL), the bifidobacteria count was significantly reduced after incubation for 30 min in
the presence of penicillin G (p 0.01). In contrast, 8HQ did not affect the bifidobacterial
count at any of the concentrations tested (Table 4). Furthermore, 2 concentrations of 8HQ
(512 and 2048 μg/mL) reduced C. perfringens counts below the detection limit. Incubation for
3 h (Table 5) did not change the pattern of 8HQ action. All 8HQ concentrations tested signifi-
cantly reduced clostridial growth (p 0.01) while showing no significant effect on bifidobac-
teria. In contrast to the selective effect of 8HQ, penicillin G at the highest concentration tested
(16 μg/mL) significantly reduced both clostridia and bifidobacteria counts (p 0.01).
Discussion
The present study focused on evaluating the in vitro selective growth-inhibitory effect of 8HQ
on C. perfringens and bifidobacteria in the complex environment of chicken ID. Prior to test-
ing, 8HQ MIC values for C. perfringens and bifidobacteria were determined using the broth
microdilution assay. In accordance with previous reports [11–14, 32], our results showed a
notable selective inhibitory effect of 8HQ on C. perfringens compared to its effect on bifidobac-
teria. The susceptibility of all strains tested was similar to that reported by Novakova et al. [12],
with a slight difference in the case of B. longum. The newly tested B. gallinarum exhibited simi-
lar resistance to 8HQ as other bifidobacteria strains. Our results are supported by those of Kim
et al. [11] and Jeon et al. [32]; however, these authors used different methods for determining
the anticlostridial/bifidobacterial effect of 8HQ.
Apart from the experimental infection of model animals, in vitro cultures of intestinal con-
tents can serve as a method for evaluating bacterial susceptibility to agents used in animal
health management [21]. In previous reports, the anticlostridial activity of several classes of
natural compounds, such as butyrate glycerides, caprylic acid, and essential oils, was measured
in media containing ID [25,26,29]. In the present study, 8HQ exerted growth-inhibitory effects
on various strains of C. perfringens in media containing autoclaved and non-autoclaved ileal
Table 4. Effects of 8-Hydroxyquinoline (8HQ) and Penicillin G on Non-Autoclaved Ileal Contents of Broiler Chickens Artificially Inoculated with C.
perfringens 56 (CFU/g)a after Incubation for 30 min at 42˚C.
Treatment Concentration (μg/mL) C. perfringens total C. perfringens (rifampicin-resistant) Bifidobacterium spp.
8HQ 32 6.82 ± 0.57* 6.52 ± 0.73* 6.94 ± 0.71
128 3.55 ± 0.51* 3.43 ± 0.71* 6.86 ± 0.58
512 < 2* < 2* 6.96 ± 0.77
2048 < 2* < 2* 6.56 ± 0.79
Penicillin G 0.25 6.14 ± 0.31* 6.23 ± 0.41* 6.20 ± 0.72
1 6.02 ± 0.23* 6.15 ± 0.42* 5.88 ± 0.34*
4 6.04 ± 0.49* 6.03 ± 0.86* 5.96 ± 0.56*
16 5.79 ± 0.45* 5.82 ± 0.50* 5.86 ± 0.35*
Control groups
Positive controlb 0 7.67 ± 0.56 7.55 ± 0.44 6.47 ± 0.92
Negative controlc 0 3.27 ± 0.37* < 2* 6.59 ± 0.59
Growth controld 0 8.12 ± 0.59 8.17 ± 0.68 < 2*
aColony-forming units, means ± SD of 3 independent experiments.
bMedium with digesta (1:1), inoculated with C. perfringens 56.
cMedium with digesta (1:1), no bacterial inoculation.
dMedium with no digesta added, inoculated with C. perfringens 56.
*Values in the same column differ significantly from the positive control (p 0.01).
doi:10.1371/journal.pone.0167638.t004
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contents. To our knowledge, this is the first study to assess the effect of 8HQ on a representa-
tive sample of beneficial microflora and clostridia simultaneously using this methodology.
The mechanism of 8HQ selectivity has not been clarified. Chelating activity is exhibited by
8HQ has a chelating activity, where it scavenges the metallic cations from its environment
while reactive oxygen species are formed. Metal ions play an important role in biological pro-
cesses, and metal homeostasis is required for maintenance of cellular functions [10]. Chelated
metals become unavailable, inhibiting certain metabolic processes [33]. For instance, RNA
synthesis is inhibited if bivalent cations required for RNA polymerase activity are chelated
[34]. In relation to our previous findings [13], it could be suggested that 8HQ causes selective
RNA polymerase inhibition because of the different capacities of bifidobacteria and clostridia
to accumulate metallic ions. It is likely that the oxidative stress defense systems of these bacte-
rial species also vary. The role of metalloenzymes in these species should explored, to identify
the mechanism of 8HQ selective antibacterial action [13]. In our study, the inhibitory effect of
8HQ was particularly notable in non-autoclaved ileal contents, with marked effects after 30
min and 3 h of incubation. One possible reason could be the presence of a thermolabile com-
pound with antibacterial activity (such as a bacterocin, or other antimicrobial protein-based
structure) [35]. However, this assumption should be investigated prior to forming any
conclusions.
In regards to 8HQ safety, the Toxicology Data Network (TOXNET, US National Library of
Medicine) reports a moderate toxicity based on oral exposure in rats (LD50 = 1.2 g/kg). There
is currently no evidence of carcinogenity. Except in high doses, 8HQ is not known to exert tox-
icity in humans. Moreover, a recent study of 8HQ found low toxicity in murine peritoneal
macrophages and no hemolytic activity in human red blood cells [36]. A preparation contain-
ing 8HQ was patented in 1989 as an oral antimicrobial agent (administered in feed or water)
for use in poultry [37]. In veterinary practice, a commercial 8HQ sulfate-containing ointment
is used for post-milking teat disinfection in dairy cattle [38]. Some halogenated 8HQ deriva-
tives, used for treating amoebiasis in humans, are considered comparatively benign, except for
Table 5. Effects of 8-Hydroxyquinoline (8HQ) and Penicillin G on Non-Autoclaved Ileal Contents of Broiler Chickens Artificially Inoculated with C.
perfringens 56 (CFU/g)a after Incubation for 3 h at 42˚C.
Treatment Concentration (μg/mL) C. perfringens total C. perfringens (rifampicin-resistant) Bifidobacterium spp.
8HQ 32 2.77 ± 1.17* 2.69 ± 1.10* 5.91 ± 0.87
128 2.29 ± 0.68* 2.28 ± 0.63* 5.98 ± 0.78
512 < 2* < 2* 5.66 ± 0.91
2048 < 2* < 2* 5.94 ± 0.86
Penicillin G 0.25 5.40 ± 0.48* 5.44 ± 0.47* 5.93 ± 0.63
1 5.83 ± 0.16* 5.63 ± 0.47* 6.52 ± 0.43
4 5.14 ± 0.25* 4.90 ± 0.49* 6.26 ± 0.75
16 3.27 ± 0.43* < 2* 5.38 ± 0.57*
Control groups
Positive controlb 0 8.13 ± 0.26 8.12 ± 0.35 6.28 ± 0.85
Negative controlc 0 3.7 ± 0.82* < 2* 6.59 ± 0.79
Inoculumd 0 8.84 ± 0.75 8.77 ± 0.69 < 2*
aColony-forming units, means ± SD of 3 independent experiments.
bMedium with digesta (1:1), inoculated with C. perfringens 56.
cMedium with digesta (1:1), no bacterial inoculation.
dMedium with no digesta added, inoculated with C. perfringens 56.
*Values in the same column differ significantly from the positive control (p 0.01).
doi:10.1371/journal.pone.0167638.t005
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frequent allergic reactions [39]. However, clioquinol, originally used as an antimicrobial agent
for amoebiasis (traveler´s diarrhea), was withdrawn from oral use in some countries after
reports of its neurotoxicity [10, 40].
A study of the pharmacokinetics of 8HQ administered intravenously in rats found biotrans-
formation to glucuronide and sulfate metabolites, followed by excretion in the urine and bile
[41]. The fate of orally administered 8HQ is considered similar, based on the findings of stud-
ies on clioquinol [42]. However, more detailed studies of 8HQ should be performed in poultry,
including a thorough toxicity determination. Furthermore, the effect of 8HQ on the total intes-
tinal microbiome should be clarified in future experiments.
Conclusion
In summary, 8HQ showed in vitro selectivity against C. perfringens over bifidobacteria when
evaluated using a broth microdilution method and assays based on its incubation in media
containing chicken ID. Our results, supported by literature-based toxicological data, suggest
that 8HQ can serve as a prospective anticlostridial agent for the treatment and prevention of
NE in poultry. However, studies that focus on its in vivo anticlostridial activity and safety are
necessary before implementing its application in veterinary practice. Molecular biology tech-
niques should be used to gain insights into the effect of 8HQ on the complex intestinal.
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